PSNL
Personalis Inc

2,715
Mkt Cap
$832.1M
Volume
838,275.00
52W High
$11.50
52W Low
$2.83
PE Ratio
-10.67
PSNL Fundamentals
Price
$9.35
Prev Close
$9.37
Open
$9.38
50D MA
$9.21
Beta
2.19
Avg. Volume
1.35M
EPS (Annual)
-$1.37
P/B
4.84
Rev/Employee
$369,493.45
Loading...
Loading...
News
all
press releases
Wall Street Zen Upgrades Personalis (NASDAQ:PSNL) to Hold
Wall Street Zen upgraded shares of Personalis from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Personalis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the BTIG 13th Annual MedTech, Digital Health, Life...
Business Wire·6d ago
News Placeholder
What 9 Analyst Ratings Have To Say About Personalis
read more...
Benzinga·8d ago
News Placeholder
Personalis (NASDAQ:PSNL) Reaches New 12-Month High - What's Next?
Personalis (NASDAQ:PSNL) Sets New 12-Month High - Should You Buy...
MarketBeat·11d ago
News Placeholder
Personalis (NASDAQ:PSNL) Trading 14.8% Higher - Still a Buy?
Personalis (NASDAQ:PSNL) Stock Price Up 14.8% - Time to Buy...
MarketBeat·12d ago
News Placeholder
Personalis, Inc. (NASDAQ:PSNL) Given Average Rating of "Moderate Buy" by Analysts
Shares of Personalis, Inc. (NASDAQ:PSNL - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eight ratings firms that are currently covering the company...
MarketBeat·14d ago
News Placeholder
Personalis (NASDAQ:PSNL) Sees Unusually-High Trading Volume - Here's Why
Personalis (NASDAQ:PSNL) Sees Unusually-High Trading Volume - Should You Buy...
MarketBeat·18d ago
News Placeholder
Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the early access launch of Real-Time Variant Tracker, a powerful new option added to its ultrasensitive NeXT...
Business Wire·22d ago
News Placeholder
Personalis (NASDAQ:PSNL) Trading Down 8.6% - What's Next?
Personalis (NASDAQ:PSNL) Stock Price Down 8.6% - Here's What Happened...
MarketBeat·26d ago
News Placeholder
Personalis Reports Select Preliminary Fourth Quarter and Full Year 2025 Results and Recent Highlights
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported certain unaudited preliminary financial and operational results for the fourth quarter and full...
Business Wire·26d ago
<
1
2
...
>

Latest PSNL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.